SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-031053
Filing Date
2019-08-09
Accepted
2019-08-09 09:00:32
Documents
3
Period of Report
2019-06-07
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A onct-8ka_20190607.htm 8-K/A 41989
2 EX-99.1 onct-ex991_46.htm EX-99.1 554866
3 EX-99.2 onct-ex992_45.htm EX-99.2 187093
  Complete submission text file 0001564590-19-031053.txt   785122
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50549 | Film No.: 191011459
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1